NO308034B1 - Nye aroylpiperidinderivater, farmasøytisk preparat inneholdende slike derivater og anvendelse derav - Google Patents
Nye aroylpiperidinderivater, farmasøytisk preparat inneholdende slike derivater og anvendelse deravInfo
- Publication number
- NO308034B1 NO308034B1 NO954067A NO954067A NO308034B1 NO 308034 B1 NO308034 B1 NO 308034B1 NO 954067 A NO954067 A NO 954067A NO 954067 A NO954067 A NO 954067A NO 308034 B1 NO308034 B1 NO 308034B1
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- new
- aroylpiperidine
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Insulating Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Suspension Of Electric Lines Or Cables (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH309194 | 1994-10-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954067D0 NO954067D0 (no) | 1995-10-13 |
NO954067L NO954067L (no) | 1996-04-15 |
NO308034B1 true NO308034B1 (no) | 2000-07-10 |
Family
ID=4248427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954067A NO308034B1 (no) | 1994-10-14 | 1995-10-13 | Nye aroylpiperidinderivater, farmasøytisk preparat inneholdende slike derivater og anvendelse derav |
Country Status (23)
Country | Link |
---|---|
US (1) | US5965562A (no) |
EP (1) | EP0707006B1 (no) |
JP (1) | JP3022951B2 (no) |
KR (1) | KR100413985B1 (no) |
CN (1) | CN1066445C (no) |
AT (1) | ATE178602T1 (no) |
AU (1) | AU705851B2 (no) |
CA (1) | CA2160444C (no) |
DE (1) | DE59505575D1 (no) |
DK (1) | DK0707006T3 (no) |
ES (1) | ES2132580T3 (no) |
FI (1) | FI114795B (no) |
GR (1) | GR3030515T3 (no) |
HU (1) | HUT74103A (no) |
IL (1) | IL115572A (no) |
MX (1) | MX9504349A (no) |
MY (1) | MY114679A (no) |
NO (1) | NO308034B1 (no) |
NZ (1) | NZ280212A (no) |
RU (1) | RU2158731C2 (no) |
SA (1) | SA96160637B1 (no) |
TW (1) | TW397825B (no) |
ZA (1) | ZA958647B (no) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW397825B (en) * | 1994-10-14 | 2000-07-11 | Novartis Ag | Aroyl-piperidine derivatives |
TW475930B (en) * | 1995-04-24 | 2002-02-11 | Novartis Ag | Novel compound, its use and pharmaceutical composition comprising it |
WO1997045119A1 (en) * | 1996-05-24 | 1997-12-04 | Novartis Ag | Use of substance p antagonists for treating social phobia |
AR018376A1 (es) | 1998-05-26 | 2001-11-14 | Novartis Ag | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento |
AU5624599A (en) * | 1998-08-25 | 2000-03-14 | Lothar Farber | Pharmaceutical uses |
US6777428B1 (en) | 1999-02-10 | 2004-08-17 | Eli Lilly And Company | 5-HT1f agonist |
RU2309953C2 (ru) | 1999-11-03 | 2007-11-10 | Эймр Текнолоджи, Инк. | Арил- и гетероарилзамещенные тетрагидроизохинолины, фармацевтическая композиция и способ лечения на их основе |
US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
JP2001294582A (ja) * | 2000-04-12 | 2001-10-23 | Fuji Chemical Industries Ltd | 光学活性アミノブチロラクトンの製造法 |
CA2415532C (en) | 2000-07-11 | 2010-05-11 | Albany Molecular Research, Inc. | Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
GB0220953D0 (en) | 2002-09-10 | 2002-10-23 | Novartis Ag | Organic compounds |
GB2394417A (en) * | 2002-10-24 | 2004-04-28 | Novartis Ag | Solid dispersion comprising a piperidine substance P antagonist and a carrier |
BRPI0409211A (pt) | 2003-04-18 | 2006-03-28 | Lilly Co Eli | composto, composição farmacêutica, métodos para ativar receptores 5-ht1f, para inibir extravasão de proteìna neuronial, e para o tratamento ou prevenção de enxaqueca em um mamìfero, e, uso de um composto |
KR101412339B1 (ko) | 2004-07-15 | 2014-06-25 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를차단하기 위한 용도 |
US8362075B2 (en) | 2005-05-17 | 2013-01-29 | Merck Sharp & Dohme Corp. | Cyclohexyl sulphones for treatment of cancer |
CN101495184A (zh) | 2005-07-15 | 2009-07-29 | Amr科技公司 | 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用 |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
SI2805945T1 (sl) | 2007-01-10 | 2019-09-30 | Msd Italia S.R.L. | Amid substituirani indazoli, kot inhibitorji poli(ADP-riboza)polimeraze(PARP) |
CA2690191C (en) | 2007-06-27 | 2015-07-28 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
AR071997A1 (es) | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
EP2413932A4 (en) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | INHIBITORS OF AKT ACTIVITY |
CA2760837C (en) | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
US8815894B2 (en) | 2009-05-12 | 2014-08-26 | Bristol-Myers Squibb Company | Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
US9034899B2 (en) | 2009-05-12 | 2015-05-19 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
CA2777043C (en) | 2009-10-14 | 2015-12-15 | Schering Corporation | Substituted piperidines that increase p53 activity and the uses thereof |
US8518907B2 (en) | 2010-08-02 | 2013-08-27 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
EP2606134B1 (en) | 2010-08-17 | 2019-04-10 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
WO2012036997A1 (en) | 2010-09-16 | 2012-03-22 | Schering Corporation | Fused pyrazole derivatives as novel erk inhibitors |
EP3766975A1 (en) | 2010-10-29 | 2021-01-20 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
WO2012143879A1 (en) | 2011-04-21 | 2012-10-26 | Piramal Healthcare Limited | A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
EP2770987B1 (en) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
WO2013165816A2 (en) | 2012-05-02 | 2013-11-07 | Merck Sharp & Dohme Corp. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
AU2013323508B2 (en) | 2012-09-28 | 2017-11-02 | Merck Sharp & Dohme Corp. | Novel compounds that are ERK inhibitors |
ES2651347T3 (es) | 2012-11-28 | 2018-01-25 | Merck Sharp & Dohme Corp. | Composiciones y métodos para el tratamiento del cáncer |
CA2895504A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
EP3525785A4 (en) | 2016-10-12 | 2020-03-25 | Merck Sharp & Dohme Corp. | KDM5 INHIBITORS |
WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
EP3833667B1 (en) | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
CN111808017B (zh) * | 2020-08-05 | 2023-11-28 | 国家纳米科学中心 | 一种含氮杂环化合物及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005525A1 (en) * | 1988-11-23 | 1990-05-31 | Pfizer Inc. | Quinuclidine derivatives as substance p antagonists |
US5145967A (en) * | 1989-04-20 | 1992-09-08 | Anaquest, Inc. | Method for preparing 4-alkoxyalkyl-4-phenylaminopiperdines and derivatives thereof |
FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
FR2654725B1 (fr) * | 1989-11-23 | 1992-02-14 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent. |
US5126455A (en) * | 1989-12-13 | 1992-06-30 | Glaxo Inc. | Preparation of substituted alkali metal piperidine-4-carboxylates |
ES2093099T3 (es) * | 1990-05-31 | 1996-12-16 | Pfizer | Preparacion de piperidinas sustituidas. |
ES2063507T3 (es) * | 1990-06-01 | 1995-01-01 | Pfizer | 3-amino-2-aril-quinuclidinas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. |
DK0550635T3 (da) * | 1990-09-28 | 1995-09-04 | Pfizer | Cykliske forbindelser med kondeserede ringe, som er analoger til nitrogenholdige ikke-aromatiske het erocykliske forbindelser |
MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
TW397825B (en) * | 1994-10-14 | 2000-07-11 | Novartis Ag | Aroyl-piperidine derivatives |
-
1995
- 1995-10-02 TW TW084110255A patent/TW397825B/zh not_active IP Right Cessation
- 1995-10-05 DK DK95810628T patent/DK0707006T3/da active
- 1995-10-05 EP EP95810628A patent/EP0707006B1/de not_active Expired - Lifetime
- 1995-10-05 ES ES95810628T patent/ES2132580T3/es not_active Expired - Lifetime
- 1995-10-05 AT AT95810628T patent/ATE178602T1/de active
- 1995-10-05 DE DE59505575T patent/DE59505575D1/de not_active Expired - Lifetime
- 1995-10-10 AU AU33174/95A patent/AU705851B2/en not_active Ceased
- 1995-10-10 MY MYPI95003026A patent/MY114679A/en unknown
- 1995-10-11 FI FI954829A patent/FI114795B/fi not_active IP Right Cessation
- 1995-10-11 IL IL11557295A patent/IL115572A/en not_active IP Right Cessation
- 1995-10-12 CA CA002160444A patent/CA2160444C/en not_active Expired - Fee Related
- 1995-10-12 NZ NZ280212A patent/NZ280212A/en not_active IP Right Cessation
- 1995-10-13 ZA ZA958647A patent/ZA958647B/xx unknown
- 1995-10-13 RU RU95117719/04A patent/RU2158731C2/ru not_active IP Right Cessation
- 1995-10-13 NO NO954067A patent/NO308034B1/no not_active IP Right Cessation
- 1995-10-13 HU HU9502973A patent/HUT74103A/hu not_active Application Discontinuation
- 1995-10-13 MX MX9504349A patent/MX9504349A/es unknown
- 1995-10-13 JP JP7265610A patent/JP3022951B2/ja not_active Expired - Fee Related
- 1995-10-13 KR KR1019950035296A patent/KR100413985B1/ko not_active IP Right Cessation
- 1995-10-13 CN CN95116776A patent/CN1066445C/zh not_active Expired - Fee Related
-
1996
- 1996-03-02 SA SA96160637A patent/SA96160637B1/ar unknown
-
1997
- 1997-10-30 US US08/961,546 patent/US5965562A/en not_active Expired - Fee Related
-
1999
- 1999-06-15 GR GR990401590T patent/GR3030515T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO954067L (no) | 1996-04-15 |
ATE178602T1 (de) | 1999-04-15 |
DK0707006T3 (da) | 1999-10-18 |
HU9502973D0 (en) | 1995-12-28 |
CN1133839A (zh) | 1996-10-23 |
US5965562A (en) | 1999-10-12 |
FI954829A0 (fi) | 1995-10-11 |
JP3022951B2 (ja) | 2000-03-21 |
ZA958647B (en) | 1996-04-15 |
MX9504349A (es) | 1997-03-29 |
AU3317495A (en) | 1996-04-26 |
CA2160444C (en) | 2006-11-28 |
CA2160444A1 (en) | 1996-04-15 |
MY114679A (en) | 2002-12-31 |
KR100413985B1 (ko) | 2004-03-26 |
GR3030515T3 (en) | 1999-10-29 |
DE59505575D1 (de) | 1999-05-12 |
FI954829A (fi) | 1996-04-15 |
JPH08176145A (ja) | 1996-07-09 |
EP0707006A1 (de) | 1996-04-17 |
ES2132580T3 (es) | 1999-08-16 |
NZ280212A (en) | 2001-10-26 |
IL115572A0 (en) | 1996-01-19 |
RU2158731C2 (ru) | 2000-11-10 |
IL115572A (en) | 2001-05-20 |
TW397825B (en) | 2000-07-11 |
HUT74103A (en) | 1996-11-28 |
CN1066445C (zh) | 2001-05-30 |
AU705851B2 (en) | 1999-06-03 |
KR960014121A (ko) | 1996-05-22 |
FI114795B (fi) | 2004-12-31 |
SA96160637B1 (ar) | 2005-06-14 |
EP0707006B1 (de) | 1999-04-07 |
NO954067D0 (no) | 1995-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308034B1 (no) | Nye aroylpiperidinderivater, farmasøytisk preparat inneholdende slike derivater og anvendelse derav | |
DE3683175D1 (de) | Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel. | |
DE3879264D1 (de) | N-substituierte azole. | |
ATE174334T1 (de) | Piperidinderivate, verwendbar als neurokinin- rezeptor-antagonisten | |
DK252286D0 (da) | Amidderivater af quinolin, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser | |
DK0481522T3 (da) | Nye mercaptoacetylamid-derivater anvendelige som inhibitorer af enkephalinase og ACE | |
BR9803295A (pt) | preparos e composições farmacêuticas contendo os mesmos. | |
NO20002169L (no) | Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser | |
DK0662471T3 (da) | Naphthalenderivater med affinitet over for melatonin-receptorer, fremgangsmåde til deres fremstilling og farmaceutiske samm | |
NO305174B1 (no) | Heterocykliske forbindelser | |
DK0461958T3 (da) | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien | |
DK0717036T3 (da) | Anvendelse af 5-acyl-1,4-dihydropyridiner til bekæmpelse af sygdomme i CNS | |
ATE186536T1 (de) | Verwendung von 1,2-überbrückten 1,4- dihydropyridinen als selektive kaliumkanalmodulatoren | |
DE59505429D1 (de) | Alkyl-5-methylsulfonyl-benzoyl-guanidin-Derivate | |
NO972943D0 (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
NO304314B1 (no) | Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler | |
DK0713865T3 (da) | Derivater af 2-aminobenzensulfonsyre og 2-aminobenzensulfonylchlorid, fremstilling og anvendelse heraf som syntesemellempro | |
DK0512522T3 (da) | Nye antibiotiske forbindelser og deres fremstilling | |
DK0582506T3 (da) | Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse af disse | |
DK0816359T3 (da) | 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
ECSP951529A (es) | Compuestos farmaceuticos | |
DK0736011T3 (da) | Anellerede dihydropyridiner og deres anvendelse til fremstilling af farmaceutiske præparater | |
NO941830D0 (no) | Karboksamid-derivater, deres fremstilling og anvendelse som terapeutika | |
IT1264596B1 (it) | Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi | |
DE60239284D1 (de) | Azotierte tetrahydropyridyl-alkyl-heterozyklen mit tnf-wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |